2-hydroxybenzothiazole has been researched along with catechol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bridewell, DJ; Ching, LM; Flanagan, JU; Fung, SP; Jamie, JF; Palmer, BD; Squire, CJ; Tijono, SM; Tomek, P; Wang, H | 1 |
| Hong, KB; Kang, S; Kim, D; Kim, H; Lee, J; Lee, M; Park, E; Song, JY; Song, KH; Van Manh, N | 1 |
2 other study(ies) available for 2-hydroxybenzothiazole and catechol
| Article | Year |
|---|---|
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
Topics: Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Humans; Hydrazines; Immune System; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Recombinant Proteins; Structure-Activity Relationship | 2013 |
2-Amino-1,3,4-thiadiazoles as Glutaminyl Cyclases Inhibitors Increase Phagocytosis through Modification of CD47-SIRPĪ± Checkpoint.
Topics: | 2022 |